~L~,XNrS have been introduced during the past decade. Of all these relaxants, succmylcholine is the only drug with a fleeting action. This short duration of action has been ascribed to a rapid enzTmatlc destruction of succinylcholine in the body ( 1, 2).
follows. A normal adult has about t~ litres of plasma. If these 8~ litres have an average esterase activity, they are capable of hydrolysing either 120 rag. of suceinyldacholine chloride per minute (17) , or 60 mg. of succinylmonocholine chloride per minute. Thus, at maxamum rates the first step of the reaction between plasma chohnesterase and succmylcholme is twice as fast as the second step (16) .
Second, the concentrations of succmyldieholine (16, 17) and suecinylmonoehohne (16) influence the rate of reaction. The maximum speed of deskuction of succinylchcholine is obtained only if tt~ enzyme is saturated with succinyldicholine, that is, at high concentrations of suecinyldicholine. If the concentration of succmyldlcholine is low, the rate of reaction is slow. The more its concentration rises, the faster it is destroyed until at very high concentrations the maximum rate is reached. The same rule holds for suecinylmonocholine.
One cannot make a general statement saying that the first step of~the hydrolysis is faster than the second step. The, ralao of reaction velocities depends on the concentrations of the two compounds. If the concentration of suecinylmonocholine is very high and the concentrataon of succinyldacholine very low, then succinylmonochohne would be hydrolysed faster. Therefore, there must be concentratxons where succmylchehohne and succinylrnonocholine are hydrolysed at the same rate, when both are sm~ultaneously exposed to the esterase. A calculation shows that the first and the second steps of the reaction must be equally fast ff the concentrataon of succmylmonocholine exceeds forty times the concentration of succihyldicholine z Or vice versa, ff they are hydrolysed at the same rate, the ratio of concentrations ts always 1 to 40 regardless of the actual concentration of succinyldicholine. This is a key figure for our later deductions.
Third, the rate of reactton is influenced by the concentration of the enzyme, which is often called the plasma level of cholinesterase. The rate of reaction is proporttonal to the concentralaon of esterase (17) ; thus, doubling the esterase level causes the reaclaon to proceed twace as fast. It is important to notice that this rule also holds at low concentrations of succinylcholine when the reaction rate is slow.
The sigmficanee of these enzymological data can now be discussed. There is no reason to assume that the en~nne acts differently to,wards sueeinylcholine in vivo than it does in vitro. Thus the circulating plasma cholinesterase of the normal adult could destroy up to 120 mg. of succinylcholine chloride per minute. We can conclude that the plasma cholir~esterase is an important l factor for the deactivahon of succinylcholine in the human body. , p 572 and equafaon 65, p. 586). For our caleulataon th~ equation was first written treating succinylchchohne as the substrate and suceinylmo'aochohne as the inhabiter Thus, the first equataon describes the rate of hydrolysis of succmyldlchohne The second equataon was set up treating succmyldlchohne as the trdubltor, and calculating the rate of hydrolysrs of the substrate succmylmonochohne If both these rates af hydrolysis are equal, the first and second equataons can be combined to form a thrrd equation By inserting numerical values for the Mlchaehs constants and the maxamum velocity rote the I htrd equataon, the above mentaoned ratJo of concentrations was obtained.
One can never reach the concentration of succiayldicholine in the circulating blood that would saturate the esterase and cause a maximum reaction rate. The esterase would act at only half the maximum rate if 1 to 2 gin. of succinylcholine were in the circulating plasma, and, also, this concentration is far m excess of practical limits. It foflows that only a fraction of the available esterase can be active at any given time. We do not yet know the blood level of succmylcholine after injection, owing to the chemical dilBcultSes of such a determination. We are, therefore, not sure how fast the circulating plasma cholinesterase acts in vivo, and whether we must expect that other factors contribute to the destruction of succinylcholine, such as the hver esterase. It has been found, however, that hardly any sueeinylcholine appears in the urine (18) .
Although only a fraction of the available plasma cholmesterase will be occupied at any given moment by succmylcholine in vivo, the size of this fraction is proportional to the esterase level. In other word,~, the esterase does not act at its full capacity whether its level is high or low.
If one gives a slow constant intravenous drip of suecinylcholine over long periods of lime, a certain degree of relaxation will be achieved and maintained as long as the drip lasts (19) . That means, the drip brings the plasma concentration of succinyldicholine to such a level thai the esterase acts at a rate whereby just as much is destroyed per minute as one puts into the system. If the rate of drip is increased, the blood level will be higher, which causes the esterase to act faster, and a new equilibrium will be established. In.other words, the blood level adjusts itself so that input and destruction .are balanced.
This equilibrium must be maintained also for succinylmonocholine. The concentration of sueeinylmonochotine shortly after the start of the drip is very. low so that it is destroyed very slowly, its concentrabon builds up, and correspondingly the destruction of suecinylmon6choline becomes faster. Ultimately it will reach a level of concentration where its rate of formation is just as fast as its rate of destruction; in other words, succmylmonoeholine will be removed just as fast as sueeinyldicholine is injected and destroyecl. If the plasma cholinesterase is the only deactivating force, it follows that at equflibri-m the plasma coneentra. tion of sueeinylmonocholine must be forty times as high as the concentration of sueeinyldieholine. Thus, from our present knowledge of the interaction between plasma cholinesterase and succinylcholine, we must predict that during slow intravenous infusion succinylmonocholine regularly accumulates.
When sutBeient suceinyldieholine was administered to achieve relaxation o]: momentary duration, succinylmonocholine could not possibly reach an effective level. Between these two extremes of rapid injection and prolonged drip, at[ 2utermediate stages of accumulation of succinyhnonocholine must be expected to occur.
No matter how effectively the plasraa eholinesterase can attack suceinylcholine in the blood, the drug in the body is not always exposed to the esterase. Very shortly after intravenous injection, a major portion of suceinyleholine must haw~ left the blood vessels to be distributed over the extracellular space. Figure ZL explains this eonciusion. It shows a schematic cross-section of single muscle fibres and capillaries in between. A motor nerve with its end-plate is shown supplying one of the muscle fibres. After intravenous injection, the drug is carried by the blood into the capillaries. In order to reach the end-plate, the site of action of succinylcholine, the drug has to leave the capillaries and it must diffuse through the extracellular space. As is known from the rapid onset of action of succinylcholine, these processes of crossing the capillary walls and travelling through the extracellular space towards the end-plate must occur with great speed. The main driving force for these processes is probably the concentration gradient. The extracellular space outside the blood vessels is roughly three times as large as the blood volume. Thus, within a short time there must be more succinylcholine outside the blood than inside.
It is not very likely that the normal extracellular fluid contains much plasma cholinesterase. Ascitic fluid (20) and cerebrospinal fluid (21) have been shown endpla÷e nerve fi bre muscle fi bres capillaries Flctrm~ 1. Schematic cross-section through single muscle fibres and capillaries. This figure demonstrates that a drug must leave the vascular bed and enter the extraeellular fluid before it can reach the end-plate. Since the extravasdular space is larger than the vascular bed, the drug becomes diluted and more of it must be outside the capillaries than inside. The figure was drawn after consultation with Dr. S. Bensley of the Department of Anatomy, University of Toronto.
to contain some, but very little, esterase. Thus, shortly after intravenous injection, a considerable portion of succinylcholine is in the extracellular space and thereby out of reach of the circulating esterase. In other words, the esterase guards the entrance to and the exit from the tissues but the esterasd cannot be blamed for irregularities which might occur in the tissues, at the site of action of suceinylcholine.
The foregoing theoretical deductions fit the following clinical experiences. First, the importance of the enzyme for the deactivation of suecinylcholine has been confirmed by several observations. There are numerous reports of cases with a low esterase level where a prolonged apnoea after succinyleholine occurred (2, 22, 23, 24, 25, 26, 27, 28 ) .
We can add here the description of some particularly instructive cases which were observed in Toronto. We had the opportunity to study three sera with extremely low esterase activity from patients who had reacted with prolonged apnoea after succinylcholine.
On repeated routine investigations these sera showed an esterase activity between 80 and 50 units; the average plasma contnin.~ 210 units. To our surprise, these esterases showed some unusual behaviour in addition to ~eir low activity. (Figure 2 gives an example.) The activity was not equally reduced towards is plotted against log concentration of benzoylcholine. Experiments on different sera are designated by different symbols. The common type of variation between different sera causes the S-shaped curves to be more or less steep. The two abnormal curves are shifted horizontally. The abnorm.llty has persisted for more than a year and is not confined to benzoylcholine. The hydrolysis of suecinylcholine is not measurable. The presence of an unknown competitive inhibitor is excluded by dialyzing experiments. various cholinesters, a~nities were lower, and they were not so easily inhibited (for instance, by neostigmine). There were no signs of an unknown inhibitor.
In short, there were changes which are hard to explain at the moment and which indicated a deeply distorted as well as a low esterase activity. Direct measurements revealed that these esterases split succinyl~holine so slowly that no accurate data were obtained, s
One of these patients was anaesthetized by Dr. MacKay at the Toronto General Hospital. The patient was 6 feet tall, weighed 180 pounds, and was in good aThe~ enzymatic hydrolysis in the Warburg apparatus was considerably slower than the spontaneous hydrolysis of suecinylcholine.
health except for a minor surgical condition. He was total y apnoeic for almost three-quarters of an hour after th~ injection of 40 rag. of succinylcholine iodide~ Consciousness returned before respiration. Two sera were from mental patients of Dr. Gtmn from the On! ario Hospital, New Toronto. They were given succinylcholine repeatedly for electroshock treatment and Dr. Gnn~ u,;ed these occasions to determine the optimal dose. One of these patients reqtth-ed only 5 rag. of succinylcholme chloride tor adequate relaxation but the apnoea lasted for 8 to 15 nnnuteS. Ten mg. caused apnoea f~ 22 to 25 minutes. The second patient requtred 10 mg. and the duration of apnoea was similar to that of the other patient, namely between 20 and 24 minutes. In these cases ~v-ith extremely low esterase activity, succmylcholme acted almost as decamethonium acts in a normal person.
There are other types of evidence which demonstrate the importance of plasma cholinesterase for the metabolism of succmylcholme. The time of apnoea can be shortened" by intravenous rejection of purified plasma cho[inesterase (28, 29, 30) . The above holds, ff the esterase is rejected prior to the administration of succinylcholine (28) . If the esterase is mjected after the administration of succmylchohne, it does not terminate an existing apnoea (,28) . Under these circumstances, the rejected esterase comes too late to guard the entrance into the lassues. Therefore, one cannot expect its full effect.
The injection of anti-cholmesterases, such as neostagmine, was repeatedly shown to increase the duration of action of succmylcholine (31, 32, 33, 84) . Evans and co-worl~ers (2) showed a close correlation between esterase level and duralaon of apnoea Foldes and co-workers (35) found a partial correlation. Among the mental patients in the Ontario Hospital, Dr. G,,nn finds no correlation between esterase level and duration of apnoea, if the few exceptional cases which were reported above are disregarded. Since there is also no correlation between dose of succinylcholme and duration of apnoea, one suspects that the electroshock itself can modify the dmataon of action of succinylcholine to a certain extent.
A second theoretical conclusion was that the esterase in the body is not acting at its maximum capacity; m other words, that there is a reserve of esterase activity which can be utilized ff the plasma concentration of suc6inylcholine is very high. This is confirmed by some experiments of Dr. Gnnn who, on several occasions, administered 1000 mg. of succinylcholme chloride by rapid intravenous injection. The apnoea lasted for only a few minutes even after this extremely high dose. The esterase activxty in these patients was normal. Similar observations were made by Borders and his co-workers (28) during anaesthesia.
Third, it has been presented as a theoretical deduction that succinylmonocholine accumulates regularly during conlanuous iIff.usiohs of succinyldicholine. The significance of this conclusion cannot be evaluated for several, reasons. It is not known whether there are more effective means th~n the plasma cholinesterase for the detoxification of succlnylmonocholine. Such factors could prevent the accumulation which the esterase would cause.
Although the esterase action permits a prediction of ratios of concentrations of the two succinylcholines, the absolute values of these concentrations are unknown. Furthermore, it is not known what drop of the plasma levels is necessary to terminate the relaxant actions. Thus, one cannot calculate how long the effects will persist after the termination of a continuous infusion or intravenous injection.
It is known that roughly twenty times more succmylmonoeholine than suceinyldieholine is necessary to produce a desired clinical effect. In view of the possible accumulation of succinylmonocholine, however, the potency of suecinylmonocholine relative to that of succinyldichohne at the human motor end-plate may be less than it appears to be from a study of intravenous injections.
Finally, we concluded that one cannot expect that all unusual reactions with succinylcholine are due to a low activity of plasma eholinesterase. During the past year, we have recexved several samples of normal plasma from patients with proIonged~apnoea after succinylcholine. Prolonged apnoea has been reported after all muscular relaxants (36), and some factor may occasionally affect the action of succinylcholine which could also affect some other relaxant.
SU~ABY
The plasma cholinesterase of a normal adult is capable of destroying in vitro up to 120 mg. per minute of suecinylchohne chloride. This great speed of destruction cannot be obtained in vivo, yet the normal plasma cholinesterase can effectively cope with a considerable excess ot" succmylcholine.
The rate of destruction .of suceinylcholine for any given concentration of succinylcholine is proportional to the concentration of plasma cholinesterase.
On slow intravenous infusion of succinyl&chohne, the plasma cholinesterase must be assumed always to cause an accumulation of succinylmonocholme so that the concentration of succinylmonochohne exceeds by about 40 times the concentxation of succinyldicholine. It is not yet clear whether this accumulation of succinylmonocholine is prevented by factors other than plasma cholinesterase, or whether this accumulation escapes clinical detection.
In order to exert its action at the neuromuscular junction, succinyleholine must enter the extravascular space where it is not exposed to plasma cholinesterase. Thus one cannot expect the esterase to be responsible for all abnormal reactions towards succinyleholine.
The sera of three patients are described, in these cholinesterase activity towards succinylcholine is too low to be measured. In all three eases the esterase has some peculiarities which are not fully cxplaJ_aed. In one of these patients injection of 5 rag. of succinylcholine chloride was found to cause profound relaxation and 15 minutes" apnoea.
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